ArticleEClinicalMedicine2023

Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial.

Tanios Bekaii-Saab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.